Related references
Note: Only part of the references are listed.Update in imaging of cancer therapy-related cardiac toxicity in adults
Esmee C. de Baat et al.
OPEN HEART (2021)
Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies
Janice M. Bonsu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from theCardio-Oncology Study Groupof theHeart Failure Associationand theCardio-Oncology Council of the European Society of Cardiology
Radek Pudil et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Representation of Patients With Cardiovascular Disease in Pivotal Cancer Clinical Trials
Janice Bonsu et al.
CIRCULATION (2019)
Patterns of comorbidities in women with breast cancer: a Canadian population-based study
Huah Shin Ng et al.
CANCER CAUSES & CONTROL (2019)
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
Peter Hanlon et al.
BMC MEDICINE (2019)
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association
Laxmi S. Mehta et al.
CIRCULATION (2018)
Cardiotoxicity of Immunotherapy: Incidence, Diagnosis, and Management
Aarti Asnani
CURRENT ONCOLOGY REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cardiovascular Complications of Cancer Therapy Best Practices in Diagnosis, Prevention, and Management: Part 2
Hui-Ming Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up
Hari K. Narayan et al.
CIRCULATION (2017)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Javid J. Moslehi
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cardiotoxicity associated with targeted cancer therapies (Review)
Zi Chen et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Impact of Funding Source on Clinical Trial Results Including Cardiovascular Outcome Trials
Hans Riaz et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV
Susanne Saussele et al.
BLOOD (2015)
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection
Rosalinda Madonna et al.
HEART FAILURE REVIEWS (2015)
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
Joerg Herrmann et al.
MAYO CLINIC PROCEEDINGS (2014)
BNP Predicts Chemotherapy-Related Cardiotoxicity and Death: Comparison with Gated Equilibrium Radionuclide Ventriculography
Dorthe Skovgaard et al.
PLOS ONE (2014)
The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates
Maria Iachina et al.
BMJ OPEN (2014)
The impact of comorbidity on cancer survival: a review
Mette Sogaard et al.
Clinical Epidemiology (2013)
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide
Mauro Feola et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials
Bostjan Seruga et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Scope and impact of financial conflicts of interest in biomedical research - A systematic review
JE Bekelman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cardiotoxicity of chemotherapeutic agents - Incidence, treatment and prevention
VB Pai et al.
DRUG SAFETY (2000)
Share Paper
